Back to Search
Start Over
Mmu-miR-125b overexpression suppresses NO production in activated macrophages by targeting eEF2K and CCNA2
- Source :
- BMC Cancer
- Publisher :
- Springer Nature
-
Abstract
- Background MicroRNAs have been shown to be important regulators of the immune response and the development of the immune system. It was reported that microRNA-125b (miR-125b) was down-regulated in macrophages challenged with endotoxin. However, little is known about the function and mechanism of action of miR-125b in macrophage activation. Macrophages use L-arginine to synthesize nitric oxide (NO) through inducible NO synthase (iNOS), and the released NO contributes to the tumoricidal activity of macrophages. Methods Luciferase reporter assays were employed to validate regulation of a putative target of miR-125b. The effect of miR-125b on endogenous levels of this target were subsequently confirmed via Western blot. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed to determine the expression level of miR-125b in macrophage. MTS assays were conducted to explore the impact of miR-125b overexpression on the cell viability of 4T1 cells. Results Here, we demonstrate that mmu-miR-125b overexpression suppresses NO production in activated macrophages and that LPS-activated macrophages with overexpressed mmu-miR-125b promote 4T1 tumor cell proliferation in vitro and 4T1 tumor growth in vivo. CCNA2 and eEF2K are the direct and functional targets of mmu-miR-125b in macrophages; CCNA2 and eEF2K expression was knocked down, which mimicked the mmu-miR-125b overexpression phenotype. Conclusions These data suggest that mmu-miR-125b decreases NO production in activated macrophages at least partially by suppressing eEF2K and CCNA2 expression. Electronic supplementary material The online version of this article (doi:10.1186/s12885-016-2288-z) contains supplementary material, which is available to authorized users.
- Subjects :
- 0301 basic medicine
Elongation Factor 2 Kinase
Cancer Research
Nitric Oxide Synthase Type II
03 medical and health sciences
Immune system
Western blot
In vivo
Cell Line, Tumor
medicine
Genetics
Macrophage
Humans
Viability assay
Cell Proliferation
Regulation of gene expression
medicine.diagnostic_test
Cell growth
business.industry
Macrophages
Nitric oxide
eEF2K
CCNA2
Macrophage Activation
In vitro
Cell biology
Endotoxins
Mmu-miR-125
MicroRNAs
030104 developmental biology
Gene Expression Regulation
Oncology
Immunology
business
Cyclin A2
Research Article
Subjects
Details
- Language :
- English
- ISSN :
- 14712407
- Volume :
- 16
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- BMC Cancer
- Accession number :
- edsair.doi.dedup.....2b08759499131769f21ffb9a84de533d
- Full Text :
- https://doi.org/10.1186/s12885-016-2288-z